A carregar...
Systemic immunosuppression in times of COVID‐19: Do we need to rethink our standards?
The current SARS‐CoV‐2 pandemic particularly endangers older people with pre‐existing cardiopulmonary and metabolic conditions. However, it is also currently under discussion whether patients under immunosuppressive therapy also have a higher risk of suffering a severe course of the COVID‐19 disease...
Na minha lista:
| Publicado no: | J Dtsch Dermatol Ges |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436367/ https://ncbi.nlm.nih.gov/pubmed/32743938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ddg.14194 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|